Term Description

The therapy to which the genetic variant identified confers resistance.

LOINC Names Get Info

Fully-Specified Name
Treatment to which genetic variant confers resistance:Prid:Pt:Bld/Tiss:Nom:
Long Common Name
Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal
Short Name
Variant assoc therapy resist
Display Name
Treatment to which genetic variant confers resistance Nom (Bld/Tiss)
Consumer Name Alpha Get Info
Treatment to which genetic variant confers resistance, Blood or tissue specimen

Part Model Get Info

  • Component
    Treatment to which genetic variant confers resistance
    LP411094-8
    • Analyte
      Treatment to which genetic variant confers resistance
      LP411094-8
      • Component Numerator
        Treatment to which genetic variant confers resistance
        LP411094-8
        • Component Numerator Core
          Treatment to which genetic variant confers resistance
          LP411094-8
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Prid
    LP6850-4
  • Time
    Pt
    LP6960-1
  • System
    Bld/Tiss
    LP7061-7
    • System Core
      Bld/Tiss
      LP7061-7
    • Super System
      NULL
       
  • Scale
    Nom
    LP7750-5
  • Method
    NULL
     

Example Answer List: LL5374-5

Source: Quest Diagnostics Inc.
AnswerCodeScoreAnswer ID
BinimetinibLA30251-5
ImatinibLA30253-1
SunitinibLA30250-7
TrametinibLA30252-3
MidostaurinLA30247-3
SorafenibLA30248-1
PonatinibLA30249-9

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.67
Last Updated
Version 2.67 (ADD)
Order vs. Observation
Observation

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Léčba vůči níž genetická varianta působí rezistenci:Přítomnost nebo identita:Časový bod:Krev/tkáň:Nominální:
el-GRGreek (Greece)Θεραπεία στην οποία η γενετική παραλλαγή προσδίδει ανθεκτικότητα:Prid:Pt:Αίμα/Ιστός:Nom:
Synonyms: MOLPATH Nom Prid Pt Αίμα Αίμα/Ιστός Θεραπεία στην οποία η γενετική παραλλαγή προσδίδει ανθεκτικότητα Ιστός
es-ESSpanish (Spain)Tratamiento al que la variante genética confiere resistencia:Presencia o identidad:Punto temporal:Sangre o tejido:Nom:
es-MXSpanish (Mexico)Tratamiento al que la variante genética confiere resistencia:Presencia o identidad:Punto temporal:Sangre o tejido:Nominal:
fr-FRFrench (France)Traitement pour variant génétique provoquant une résistance:Identification:Ponctuel:Sang/Tissu:Résultat nominal:
it-ITItalian (Italy)Trattamento a cui la variante genetica conferisce resistenza:Prid:Pt:Sangue/Tess:Nom:
Synonyms: Patologia molecolare Presenza o Identità Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & Strisci
zh-CNChinese (China)因为遗传变异而导致耐受的治疗:存在与否或特征标识:时间点:全血/组织:名义型:
Synonyms: 全血或组织;血液/组织;血液或组织 分子病理学;分子病理学试验 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 因为(因)遗传变异(遗传性变异、基因变异、传性变型、遗传变异体、基因变异体)而导致(造成、带来、赋予、造就、致使)耐受(抵抗、耐受性、抵抗力、耐药性、抗性、耐性、耐药、抗药、抗药性)的治疗(治疗方法、治疗方法) 存在;存在与否;特征标识;身份;身份标识 抗力 抗耐性 抵抗力 抵抗性 时刻;随机;随意;瞬间 未作说明的组织;组织;组织 & 涂片 电阻 耐性 血;血液 阻力

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=93344-0